How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains

September 6, 2024

We own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on the US soil and the US government would have the right of first refusal on production on the facility. And when the US government does not want to source material from that facility, the company is free to manufacture other materials and sell it to whoever they wish to sell.

More To Explore

Tech View: Nifty reclaims 200-DMA. What are cues for traders on Thursday?

Indian indices began 2025 positively, with Sensex rising 368 points and Nifty gaining 98 points, driven by auto and banking stocks. Analysts foresee resistance near

January 1, 2025

Market Outlook for 2025: Nifty faces tough resistance at 23,780, says Rohit Srivastava

So, on the downside, then we will again look at retesting 23,200, the lows that we made last month and if that breaks, then possibly

January 1, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003